Skip to main content
DuChemBio Co, LTD logo

DuChemBio Co, LTD — Investor Relations & Filings

Ticker · 176750 ISIN · KR7176750008 KO Manufacturing
Open in API
Filings indexed 291 across all filing types
Latest filing 2021-08-31 Major Shareholding Noti…
Country KR South Korea
Listing KO 176750

About DuChemBio Co, LTD

http://www.duchembio.com/en/

DuChemBio Co., Ltd. is a pharmaceutical company specializing in the development, manufacturing, and commercialization of radiopharmaceuticals. The company focuses on products for both diagnosis and treatment, with a primary emphasis on positron emission tomography (PET) imaging tracers. Its portfolio targets key therapeutic areas, including oncology for cancer detection and neurology for conditions such as Alzheimer's and Parkinson's disease. The company's mission is to develop novel radiopharmaceuticals and achieve successful commercialization on a global scale.

Recent filings

Filing Released Lang Actions
최대주주변경
Major Shareholding Notification Classification · 100% confidence The document is a formal regulatory filing from a Korean company (DuChemBio) announcing a change in its largest shareholder (maximum shareholder). It details the before-and-after shareholding structure, the reason for the change (merger), and subsequent changes to the board of directors. This type of disclosure regarding ownership structure and control is classified as a general regulatory filing under the RNS category as it does not fit into specific categories like DIRS (insider trading) or MRQ (major shareholding notification by an investor).
2021-08-31 Korean
[기재정정]주요사항보고서(회사합병결정)
M&A Activity Classification · 100% confidence The document is a 'Major Report' (주요사항보고서) regarding a corporate merger (회사합병 결정) filed by DuchemBio. It details the merger process, including the merger ratio, valuation methods, and changes to the merger schedule due to public holidays. This type of filing is a regulatory disclosure concerning M&A activity. While it is a 'correction' (정정신고) of a previous filing, it falls under the category of M&A activity announcements.
2021-08-06 Korean
임시주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official report of the results from an Extraordinary General Meeting (EGM) of shareholders for the company 'DuChemBio'. It details the voting outcomes for various agenda items, including the approval of a merger agreement, amendments to the articles of incorporation, and the appointment of directors and auditors. This falls directly under the category of Declaration of Voting Results.
2021-07-26 Korean
투자설명서
Investor Presentation Classification · 95% confidence The document is a 'Securities Registration Statement' (증권신고서) regarding a merger and split-merger (분할합병) between DuChemBio and CareCamp. It contains detailed information on merger ratios, risk factors, financial summaries, and legal conditions for the transaction. In the context of financial filings, this type of document is a formal regulatory filing related to M&A activity. Since it is a comprehensive registration statement for a merger, it falls under the M&A Activity category.
2021-07-19 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a formal 'Notice of Extraordinary General Meeting of Shareholders' (주주총회소집공고) issued by DuChemBio. It contains the meeting agenda, details on voting rights, procedures for exercising appraisal rights (주식매수청구권) regarding a merger, and management reference materials. This document is a standard proxy statement sent to shareholders to inform them of an upcoming meeting and solicit their votes on specific proposals, which fits the definition of a Proxy Solicitation & Information Statement.
2021-07-09 Korean
[기재정정]증권신고서(합병)
M&A Activity Classification · 100% confidence The document is a 'Securities Registration Statement' (증권신고서) related to a merger (합병) between DuChemBio and CareCamp. It contains detailed financial tables, risk factors, and legal disclosures required for a corporate merger filing. This is a formal regulatory document submitted to the Financial Supervisory Service (FSS) in South Korea, which falls under the category of M&A activity (TAR) as it pertains to merger proposals and related financial disclosures.
2021-07-07 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.